Virginia Retirement Systems ET AL Acquires New Position in Steris Corp. (STE)
Virginia Retirement Systems ET AL acquired a new position in shares of Steris Corp. (NYSE:STE) during the second quarter, Holdings Channel reports. The firm acquired 5,200 shares of the company’s stock, valued at approximately $358,000.
Several other hedge funds and other institutional investors also recently modified their holdings of the stock. CENTRAL TRUST Co raised its position in shares of Steris Corp. by 334.9% in the second quarter. CENTRAL TRUST Co now owns 2,857 shares of the company’s stock worth $196,000 after buying an additional 2,200 shares in the last quarter. BKD Wealth Advisors LLC bought a new position in shares of Steris Corp. during the second quarter worth approximately $208,000. World Asset Management Inc raised its position in shares of Steris Corp. by 0.3% in the second quarter. World Asset Management Inc now owns 4,197 shares of the company’s stock worth $289,000 after buying an additional 13 shares in the last quarter. Commonwealth Equity Services Inc raised its position in shares of Steris Corp. by 1.3% in the second quarter. Commonwealth Equity Services Inc now owns 4,498 shares of the company’s stock worth $309,000 after buying an additional 58 shares in the last quarter. Finally, Mount Lucas Management LP bought a new position in shares of Steris Corp. during the first quarter worth approximately $313,000. 91.58% of the stock is currently owned by institutional investors and hedge funds.
Shares of Steris Corp. (NYSE:STE) opened at 71.27 on Friday. Steris Corp. has a 12-month low of $61.38 and a 12-month high of $78.77. The firm has a market cap of $6.14 billion, a price-to-earnings ratio of 40.94 and a beta of 1.14. The firm has a 50-day moving average price of $71.44 and a 200-day moving average price of $70.40.
Steris Corp. (NYSE:STE) last released its earnings results on Tuesday, August 9th. The company reported $0.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.77 by $0.02. Steris Corp. had a return on equity of 10.72% and a net margin of 5.52%. The business had revenue of $638.40 million for the quarter, compared to analyst estimates of $639.04 million. During the same quarter in the prior year, the company posted $0.62 earnings per share. Steris Corp.’s revenue was up 45.1% on a year-over-year basis. Equities research analysts anticipate that Steris Corp. will post $3.90 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 27th. Investors of record on Tuesday, August 30th were issued a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a yield of 1.57%. The ex-dividend date of this dividend was Friday, August 26th. This is a positive change from Steris Corp.’s previous quarterly dividend of $0.25. Steris Corp.’s dividend payout ratio is presently 68.71%.
Separately, Zacks Investment Research raised Steris Corp. from a “sell” rating to a “hold” rating in a report on Friday, September 2nd.
In related news, Director Richard Martin Steeves sold 204,778 shares of the company’s stock in a transaction dated Wednesday, September 7th. The stock was sold at an average price of $71.19, for a total transaction of $14,578,145.82. Following the sale, the director now owns 165,434 shares in the company, valued at $11,777,246.46. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Daniel A. Carestio sold 2,681 shares of the business’s stock in a transaction that occurred on Friday, August 12th. The stock was sold at an average price of $71.04, for a total value of $190,458.24. The disclosure for this sale can be found here. Corporate insiders own 2.52% of the company’s stock.
About Steris Corp.
STERIS Corporation (STERIS) is a provider of infection prevention and other procedural products and services. The Company is focused on healthcare, pharmaceutical and research. The Company operates through three business segments: Healthcare, Life Sciences and STERIS Isomedix Services. The Healthcare segment provides surgical, sterile processing, infection prevention and gastrointestinal solutions.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris Corp. (NYSE:STE).
Receive News & Ratings for Steris Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Corp. and related companies with MarketBeat.com's FREE daily email newsletter.